The acquisition illustrates the Group’s strategy to strengthen its position in the entire value chain of diagnosis and stresses the pivotal role of clinical trial services. It offers Viroclinics-DDL a ...

French medical laboratory services operator Cerba HealthCare said it has entered negotiations with EQT Private Equity about a potential investment. The deal is expected to result in the exit of ...

BAAR-ZUG, Switzerland, and MONTREAL, Canada, Jan. 22, 2017 /CNW Telbec/ – Partners Group, the global private markets investment manager, acting on behalf of its clients, and the Public Sector Pension ...

SAINT OUEN L’AUMÔNE, France & TEL AVIV, Israel--(BUSINESS WIRE)--Cerba, the foremost specialty clinical pathology reference, and Taliaz, an Israeli digital health company dedicated to improving mental ...

Cerba Research established its United States presence as a leading clinical diagnostics and clinical laboratory services provider when it opened a New York facility 20 years ago. To further support ...

Delivering the promise of precision and predictive medicine to help people live healthier lives. Cerba Research, the industry-leading provider of diagnostic solutions for clinical research, is ...

The acquisition points up the Group’s ambition to provide its clinical research customers with best-in-class scientific input and critical flexibility for their drug development programs. It will ...

Frankfurt am Main, December 07, 2020 -- Moody's Investors Service ("Moody's") has today affirmed Constantin Investissement 3 S.A.S.' (Cerba or the company) B2 corporate family rating (CFR), its B2-PD ...

Bonds of Cerba Healthcare SAS tumbled this week as private equity owner EQT AB reviews options for the French laboratory firm’s debt stack. EQT has been discussing possible scenarios with Houlihan ...

Cerba Research announces membership of HKBMIA to act as an advisor on speciality testing and routine clinical trials testing to advance research and health while supporting Asia pacific healthcare ...

EQT AB is nearing an agreement to acquire Cerba HealthCare in a deal valuing the French laboratories firm at about 4.5 billion euros ($5.3 billion) including debt, people with knowledge of the matter ...